𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Delayed elimination of triamterene and its active metabolite in chronic renal failure

✍ Scribed by H. Knauf; W. Möhrke; E. Mutschler

Publisher
Springer
Year
1983
Tongue
English
Weight
401 KB
Volume
24
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of torasemide and its m
Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure
✍ H. Spahn; H. Knauf; E. Mutschler 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 344 KB

The pharmacokinetics of 20 mg torasemide i.v. has been studied in 7 healthy controls and 9 patients with varying degrees of renal impairment. Torasemide had a t1/2 of about 4h which was independent of kidney function, as the nonrenal clearance of torasemide was 3-times greater than its renal clearan

Pharmacokinetics of oral diltiazem and f
Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure
✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)

Pharmacokinetics of intravenous diltiaze
Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers
✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

The pharmacokinetics of diltiazem were studied in seven patients with chronic renal failure (CRF) not requiring dialysis and in three healthy volunteers after a rapid i.v. infusion of 20mg. Mean plasma concentrations at the end of infusion were 3.15 times higher in patients with CRF than in healthy

The disposition of paracetamol and the a
The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure
✍ U. Martin; R. M. Temple; R. J. Winney; L. F. Prescott 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 385 KB

We have compared the disposition of oral paracetamol (1.0 g t.d.s. for 10 days) in 6 healthy volunteers and 6 conservatively-managed patients with chronic renal failure (mean plasma creatinine 451 mumol.l-1). Blood was sampled daily for 10 days before the morning dose of paracetamol. Each day the pr